Skip to main content
PDEX logo

PDEX · Pro Dex Inc

Track PDEX — free
$73.41 +11.66 (+18.88%) At close · Sep 4
Market Cap
$235.16M
Shares
3.20M

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Revenue
$77.55M +16.5%
FY2026 Revenue FY2011–FY2026
Net Income
$13.66M +52.2%
FY2026 Net Income FY2011–FY2026
Gross Margin
31.38% +2.1pp
FY2026 Gross Margin FY2011–FY2026
Operating Margin
16.75% +0.7pp
FY2026 Operating Margin FY2011–FY2026
Diluted EPS
$4.12 +54.3%
FY2026 Diluted EPS FY2011–FY2026
Operating Cash Flow
$7.24M +530.6%
FY2026 Operating Cash Flow FY2011–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
$77.55M $66.59M $53.84M $46.09M $42.04M $38.03M $34.83M $27.17M $22.47M $21.94M $20.16M $13.38M $10.81M $722K $6.71M $24.06M
$53.21M $47.08M $39.29M $33.34M $28.91M $24.45M $21.69M $17.39M $14.52M $14.76M $14.27M $9.68M $7.85M $8.53M $11.84M $13.92M
$24.34M $19.51M $14.55M $12.75M $13.13M $13.58M $13.14M $9.78M $7.94M $7.19M $4.92M $3.7M $2.97M $3.72M $5.42M $10.14M
31.38% 29.3% 27.02% 27.66% 31.24% 35.7% 37.73% 35.99% 35.36% 32.75% 24.4% 27.68% 27.43% 514.68% 80.72% 42.15%
$3.35M $3.64M $3.19M $2.8M $2.98M $4.38M $2.32M $1.88M $1.89M $1.23M $1.2M $1.67M $1.48M $1.79M $2.07M $1.89M
$5.01M $4.84M $4.07M $4.03M $4.9M $4.08M $3.19M $2.49M $2.29M $2.53M $1.88M $1.96M $1.71M $2.57M $3.18M $3.17M
$8M $5.19M
$60K $28K $28K $37K $16K $14K $14K $22K $20K $20K $117K $44K
$1.39M $1.24M $1.16M $857K $726K $686K $573K $438K $557K $555K $614K $578K $527K $582K $647K $697K
$11.34M $8.82M $7.38M $6.99M $8.01M $9.05M $6.08M $4.78M $5.55M $4.45M $4.11M $4.61M $3.78M $5.61M $6.78M $6.66M
$12.99M $10.69M $7.17M $5.76M $5.12M $4.53M $7.07M $5M $2.39M $2.74M $807K -$902K -$814K -$1.9M -$1.37M $3.48M
16.75% 16.05% 13.32% 12.5% 12.19% 11.9% 20.28% 18.39% 10.65% 12.47% 4% -6.74% -7.53% -262.47% -20.34% 14.46%
$14.39M $11.93M $8.33M $6.62M $5.85M $5.21M $7.64M $5.44M $2.95M $3.29M $1.42M -$324K -$287K -$1.31M -$718K $4.18M
$812K $829K $558K $533K $464K $352K $236K $220K $7000 $12K $37K $6000 $8000 $11K -$36K -$148K
$6000 $12K
$5.02M $1.37M -$4.54M $3.67M $571K $3.09M $836K $449K $218K $15K $321K $456K $59K -$8000 -$36K $148K
$61K
$5.66M $2.12M $28K $1.33M $25K $356K
$18.02M $12.06M $2.63M $9.43M $5.69M $7.62M $7.9M $5.45M $2.61M $2.75M $1.13M -$446K -$755K -$1.9M -$1.4M $3.33M
$4.35M $3.08M $507K $2.35M $1.12M $1.45M $1.79M $1.3M $989K -$2.09M $25K -$44K -$104K -$39K -$441K $530K
$13.66M $8.98M $2.13M $7.07M $4.57M $6.17M $6.11M $4.15M $1.62M $5.08M $822K -$365K -$488K -$1.78M -$876K $2.64M
17.62% 13.48% 3.95% 15.35% 10.88% 16.22% 17.55% 15.27% 7.22% 23.17% 4.08% -2.73% -4.51% -247.09% -13.06% 10.97%
$5.82M $5.08M $3.75M $1.44M $5.12M $822K
USD/shares $4.24 $2.73 $0.61 $1.98 $1.26 $1.63 $1.56 $0.99 $0.38 $1.26 $0.20 -$0.09 -$0.27 $0.81
USD/shares $4.12 $2.67 $0.60 $1.95 $1.21 $1.57 $1.50 $0.97 $0.37 $1.25 $0.20 -$0.09 -$0.27 $0.80
shares 3.23M 3.29M 3.5M 3.57M 3.64M 3.8M 3.91M 4.19M 4.3M 4.04M 4.14M 4.17M 3.49M 3.32M 3.27M 3.26M
shares 3.32M 3.36M 3.57M 3.64M 3.76M 3.94M 4.08M 4.3M 4.34M 4.08M 4.17M 4.17M 3.49M 3.32M 3.27M 3.29M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2012–FY2026: $27.63M in buybacks.

Debt Profile

Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.

Debt data is being processed. Please check back later.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
3.14×
Peer median 1.54×
EV/EBIT
18.73×
Peer median 27.64×
P/E (TTM)
17.82×
Peer median 26.80×

Peer medians compare against the 18 similar-size Medical Instruments & Supplies companies (of 46 listed).

Valuation over time computed as of each quarter's filing date

Key facts CIK 788920 CUSIP 74265M205 13F (30d) 46 filings 46 filers Visit website Investor relations